- Free from Publisher A Gokcel, H Karakose, EM Ertorer, N Tanaci, … - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—One patient in the sibutramine group was excluded during the study
period because of hypertension; thus, a total of 29 data sets were analyzed for
this group. In the placebo group, five patients had to be excluded because ... Cited by 81 - Related articles - BL Direct - All 5 versions
M Serrano-Rios, N Melchionda, E Moreno- … - Diabetic Medicine, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 51 - Related articles - BL Direct - All 4 versions
CA Dujovne, JH Zavoral, E Rowe, CM Mendel - American Heart Journal, 2001 - pt.wkhealth.com From the a Kansas Foundation for Clinical Pharmacology, Radiant Research-Kansas
City, Overland Park, Kan, the b Preventive Cardiology Institute, Radiant
Research-Minneapolis, and Fairview Southdale Hospital, Edina, Minn, and c ... Cited by 66 - Related articles - BL Direct - All 12 versions
N Finer, SR Bloom, GS Frost, LM Banks, J … - Diabetes Obesity and Metabolism, 2000 - interscience.wiley.com Methods: Randomised, placebo-controlled, double-blind, parallel-group, 12-week
study conducted at two hospital-based obesity/diabetes clinics. Patients were
men and women aged 30–65 years, with bmi > 26 kg/m 2 and ≤ 35 kg/m 2 ... Cited by 149 - Related articles - BL Direct - All 6 versions
K Fujioka, TB Seaton, E Rowe, CA Jelinek, P … - Diabetes, Obesity and Metabolism, 2000 - ingentaconnect.com Weight loss with sibutramine improves glycaemic control and ... K. Fujioka, 1
TB Seaton, 2 E. Rowe, 2 CA Jelinek, 2 P. Raskin, 3 HE Lebovitz, 4 ... SP
Weinstein 2 and the Sibutramine/Diabetes Clinical Study Group* Cited by 137 - Related articles - BL Direct - All 4 versions
BP Hazenberg - Cardiology, 2000 - content.karger.com Objectives: To compare weight loss efficacy, safety and tolerability of
sibutramine and placebo in mildly to moderately obese hypertensive subjects; to
assess the effect of weight loss on blood pressure. Design: Randomized, ... Cited by 71 - Related articles - BL Direct - All 7 versions
GEM Cuellar, AM Ruiz, MCR Monsalve, A … - Obesity, 2000 - nature.com Results: 22 of 35 patients in the sibutramine group and 9 of 34 patients in the
placebo group completed the trial. The high dropout rate in the sibutramine
group was due to adverse events in 3 cases, lack of efficacy (as judged by ... Cited by 51 - Related articles - BL Direct - All 3 versions
A Wirth, J Krause - Jama, 2001 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Treatment of ... Cited by 229 - Related articles - BL Direct - All 8 versions
IG Smith, MA Goulder… - Journal of Family Practice, 2001 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Randomized placebo-controlled
trial of long-term treatment with sibutramine in mild to moderate obesity. ... Cited by 119 - Related articles - Cached - BL Direct - All 3 versions
FG McMahon, K Fujioka, BN Singh, CM … - Archives of Internal Medicine, 2000 - archinte.highwire.org Patients and Methods Obese patients with a body mass index (BMI, calculated as
weight in kilograms divided by the square of height in meters) between 27 and 40
and a history of hypertension controlled with a calcium channel blocker ... Cited by 221 - Related articles - BL Direct - All 5 versions
